先端巨大症（Acromegaly）：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Acromegaly 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acromegaly to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acromegaly to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Acromegaly 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Acromegaly Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Acromegaly 33
Apr 22, 2014: Aspireo Reports Data in Further Phase Ib Study 33
Mar 21, 2014: ATL1103 Acromegaly Phase II Trial Recruitment Completed 33
Dec 23, 2013: Positive Results Achieved from Interim Analysis of ATL1103 Phase II Trial 34
Nov 26, 2013: ATL1103 Phase II Trial Update 35
Oct 17, 2013: ATL1103 Phase II Trial Update – Interim Analysis 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Ipsen S.A. 38
Clinical Trial Overview of Ipsen S.A. 38
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Pfizer Inc. 42
Clinical Trial Overview of Pfizer Inc. 42
Endo International plc 43
Clinical Trial Overview of Endo International plc 43
Aspireo Pharmaceuticals Ltd. 44
Clinical Trial Overview of Aspireo Pharmaceuticals Ltd. 44
Ambrilia Biopharma Inc. 45
Clinical Trial Overview of Ambrilia Biopharma Inc. 45
Glide Pharmaceutical Technologies Limited 46
Clinical Trial Overview of Glide Pharmaceutical Technologies Limited 46
Camurus AB 47
Clinical Trial Overview of Camurus AB 47
Antisense Therapeutics Limited 48
Clinical Trial Overview of Antisense Therapeutics Limited 48
Chiasma, Inc. 49
Clinical Trial Overview of Chiasma, Inc. 49
Clinical Trial Overview of Top Institutes / Government 50
Cedars-Sinai Medical Center 50
Clinical Trial Overview of Cedars-Sinai Medical Center 50
Aarhus University 51
Clinical Trial Overview of Aarhus University 51
The Federico II University 52
Clinical Trial Overview of The Federico II University 52
Massachusetts General Hospital 53
Clinical Trial Overview of Massachusetts General Hospital 53
Erasmus MC 54
Clinical Trial Overview of Erasmus MC 54
Barts and The London NHS Trust 55
Clinical Trial Overview of Barts and The London NHS Trust 55
National Center for Research Resources 56
Clinical Trial Overview of National Center for Research Resources 56
The National Institute of Diabetes and Digestive and Kidney Diseases 57
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 57
Herlev Hospital 58
Clinical Trial Overview of Herlev Hospital 58
Columbia University 59
Clinical Trial Overview of Columbia University 59
Five Key Clinical Profiles 60
Appendix 114
Abbreviations 114
Definitions 114
Research Methodology 115
Secondary Research 115
About GlobalData 116
Contact Us 116
Disclaimer 116
Source 116